ORIGINAL RESEARCH
Accepted on 10 Sep 2025
Computational drug repurposing reveals Alectinib as a potential lead targeting Cathepsin S for therapeutic developments against cancer and chronic pain
doi 10.3389/fbinf.2025.1666573
- 123 views
671
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.